Federated Hermes’s Apyx Medical APYX Stock Holding History

Federated Hermes’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-186	Closed	-$435	–	2116
2022 Q4	$435	Buy	+186	New	+$568	﹤0.01%	2092
2021 Q2	–	Sell	-79	Closed	-$1K	–	2201
2021 Q1	$1K	Hold	79	–	–	﹤0.01%	2152
2020 Q4	$1K	Buy	+79	New	+$524	﹤0.01%	2154
2020 Q2	–	Sell	-51	Closed	-$1K	–	2237
2020 Q1	$1K	Sell	51 -172	-77%	-$1.16K	﹤0.01%	2075
2019 Q4	$2K	Buy	223 +72	+48%	+$520	﹤0.01%	2020
2019 Q3	$1K	Buy	+151	New	+$1.07K	﹤0.01%	2070
2019 Q2	–	Sell	-1,456	Closed	-$9K	–	2161
2019 Q1	$9K	Sell	1,456 -116	-7%	-$897	﹤0.01%	1882
2018 Q4	$10K	Buy	1,572 +902	+135%	+$5.46K	﹤0.01%	1867
2018 Q3	$5K	Buy	+670	New	+$3.72K	﹤0.01%	2049
2017 Q2	–	Sell	-108	Closed	-$1K	–	2119
2017 Q1	$1K	Hold	108	–	–	﹤0.01%	2053
2016 Q4	$1K	Buy	+108	New	+$481	﹤0.01%	2039

Other funds holding APYX

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Federated Hermes's APYX Position: Q1 2023 in Review

Federated Hermes sold out of Apyx Medical (APYX) in Q1 2023, closing a stake of 186 shares — an estimated $435 sold.

Federated Hermes first reported a position in APYX in Q4 2016 and held it in 11 quarters. The position peaked at $10K in Q4 2018. 55 funds tracked by Wall St. Rank hold APYX as of Q1 2023.

Federated Hermes reported no remaining Apyx Medical position as of Q1 2023 after selling out during the quarter.
Federated Hermes sold 186 Apyx Medical shares in Q1 2023, an estimated $435.
Federated Hermes first reported a position in Apyx Medical in Q4 2016 and held it in 11 quarters.
Federated Hermes's Apyx Medical position peaked at $10K in Q4 2018.
55 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2023.

Based on Federated Hermes's 13F filing for Q1 2023, filed 8 May 2023.